Lama Penggunaan Kontrasepsi Depo Medroksi Progesteron Asetat dengan Indeks Massa Tubuh dan Kadar Kolesterol Total

Authors

  • Suratiah Suratiah Poltekkes Kemenkes Denpasar
  • Nengah Runiari Poltekkes Kemenkes Denpasar
  • Dewa Ayu Ketut Surinati Poltekkes Kemenkes Denpasar
  • Ni Nyoman Hartati Poltekkes Kemenkes Denpasar, Indonesia
  • Dewa Made Ruspawan Poltekkes Kemenkes Denpasar

DOI:

https://doi.org/10.33992/jgk.v14i1.1563

Keywords:

Lama pemakaian, DMPA, IMT, Kolesterol

Abstract

BMI and total blood cholesterol levels in Depo Medroxy Progesteron Asetate family planning users in the work area of Puskesmas IV Denpasar Selatan in 2021. This study used a non-probability sampling technique with purposive sampling as many as 32 respondents. Collecting instruments through interviews and measuring Basal Metabolisme Indekx by measuring height and weight and measuring cholesterol levels using the EasyTouch GCU Kit. The results showed that most of the users of injection contraceptive Depo Medroxy Progesteron Asetate were 22 people 68.8% ≥24 months, most of the users of Depo Medroxy Progesteron Asetate injection contraception had a heavy Basal Metabolisme Indekx 40.6%  and cholesterol normal levels 68.8%, rather high cholesterol 25.0% and high cholesterol 6.3%. Hypothesis testing used is the contingency coefficient with a Basal Metabolisme Indekx value of p = 0.001 (p<0.05) and a cholesterol value of p = 0.037 (p<0.05), so there is a relationship between the length of time using Depo Medroxy Progesteron Asetate injection contraceptives and Basal Metabolisme Indekx. and total cholesterol levels in the blood in Depo Medroxy Progesteron Asetate family planning acceptors users in the work area of Puskesmas IV South Denpasar in 2021. Based on the results of the study, it is hoped that this can be taken into consideration in providing education and counseling on how to overcome the side effects that occur, so that family planning acceptors Depo Medroxy Progesteron Asetate contraceptives are the only hormonal contraceptives that consistently have an effect on weight gain which results in changes in BMI and affects the lipid profile resulting in increased cholesterol levels. The purpose of this study was to determine the relationship between the duration of use of DMPA injection contraceptives with can overcome the problem of increasing. weight arising from the use of Depo Medroxy Progesteron Asetate family planning and the importance of measuring cholesterol levels regularly in Depo Medroxy Progesteron Asetate family planning acceptors.

References

Central Intelligence Agency. The World Factbook — Country Comparison: Population. CIA Office of Public Affairs. 2017.

BKKBN. Survei Demografi Dan Kesehatan : Kesehatan Reproduksi Remaja 2017. Badan Kependud dan Kel Berencana Nas. 2017;

Kemenkes RI. Survey Demografi dan Kesehatan Indonesia. Survei Demografi dan Kesehatan Indonesia 2017. 2017.

Kementerian Kesehatan RI Badan Penelitian dan Pengembangan. Hasil Utama Riset Kesehatan Dasar. Kementrian Kesehatan Republik Indonesia. 2018.

Sari F. Studi Komparasi Kadar Glukosa Darah Sewaktu akseptor KB suntik kombinasi dan progestin di Bpm Yosi Trihana Kabupaten Klaten Jawa Tengah. J Kesehat. 2017;8.

Hartanto. Keluarga Berencana dan Kontrasepsi. Jakarta : Sinar Harapan.; 2010.

Dalam T, Ngesti, Herawati, Tutik, Saragih L. Lama Pemakaian Alat Kontrasepsi Hormonal Suntik DMPA dan Gangguan Kardiovaskuler Poltekkes Kemenkes Malang. 2015;

Agustiyanti, Fatimah, Aruben. Hubungan Asupan Makanan Aktivitas Fisik dan Penggunaan Kontrasepsi Hormonal dengan Kadar Kolesterol darah (Studi Pada Wanita Keluarga Nelayan usia 30-40 tahun Di Tambak Lorok Semarang tahun 2017. 2017;

Ratna Novalia Sari. Kontrasepsi Hormonal Suntik Depo Medroxyprogesterone Acetate (DMPA) sebagai Salah Satu Penyebab Kenaikan Berat Badan. 2015;

Downloads

Published

2021-12-25

Issue

Vol. 14 No. 1 (2021): Jurnal Gema Keperawatan

Section

Articles

Citation Check

License

  1. Penulis menyimpan hak cipta dan memberikan jurnal hak penerbitan pertama naskah secara simultan dengan lisensi di bawah Creative Commons Attribution License yang mengizinkan orang lain untuk berbagi pekerjaan dengan sebuah pernyataan kepenulisan pekerjaan dan penerbitan awal di jurnal ini.
  2. Penulis bisa memasukkan ke dalam penyusunan kontraktual tambahan terpisah untuk distribusi non ekslusif versi kaya terbitan jurnal (contoh: mempostingnya ke repositori institusional atau menerbitkannya dalam sebuah buku), dengan pengakuan penerbitan awalnya di jurnal ini.
  3. Penulis diizinkan dan didorong untuk mem-posting karya mereka online (contoh: di repositori institusional atau di website mereka) sebelum dan selama proses penyerahan, karena dapat mengarahkan ke pertukaran produktif, seperti halnya sitiran yang lebih awal dan lebih hebat dari karya yang diterbitkan. (Lihat Efek Akses Terbuka).

Most read articles by the same author(s)

<< < 1 2 3